Biocon Limited
BIOCON
주식 순위
#3334
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
주가
$3.84
마지막 동기화: 2026-10-16
시가총액
$5.25B
변동 (1일)
-0.85%
변동 (1년)
-5.08%
국가
IN
거래 Biocon Limited (BIOCON)
카테고리
Healthcare
Biocon Limited (BIOCON)의 EPS
June 2026 기준 EPS TTM: $0.04
Biocon Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.04입니다. 2024년 말에는 회사의 EPS가 $0.10였으며, 이는 2023년의 EPS $0.05와 증가입니다.
Biocon Limited의 EPS 기록 (2004 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $0.04 | -62.50% |
| 2025 | $0.10 | -3.51% |
| 2024 | $0.10 | 117.16% |
| 2023 | $0.05 | -34.17% |
| 2022 | $0.07 | -15.85% |
| 2021 | $0.09 | 1.55% |
| 2020 | $0.08 | -23.87% |
| 2019 | $0.11 | 127.22% |
| 2018 | $0.05 | -39.53% |
| 2017 | $0.08 | 13.76% |
| 2016 | $0.07 | 6.33% |
| 2015 | $0.07 | 12.95% |
| 2014 | $0.06 | -26.35% |
| 2013 | $0.08 | 40.32% |
| 2012 | $0.06 | -19.09% |
| 2011 | $0.07 | 25.58% |
| 2010 | $0.06 | 249.38% |
| 2009 | $0.02 | -84.00% |
| 2008 | $0.10 | 142.13% |
| 2007 | $0.04 | 21.11% |
| 2006 | $0.03 | -14.32% |
| 2005 | $0.04 | 27.16% |
| 2004 | $0.03 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $17.32 | 46,086.67% |
US
|
|
| $-7.98 | -21,380.00% |
US
|
|
| $-5.29 | -14,206.67% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 73,873.33% |
NL
|
